No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Addition of selumetinib to radioactive iodine does not improve remission rates in differentiated thyroid cancers

byTeddy Guo

December 20, 2022

in StudyGraphics

Reading Time: 1 min read

MRI enhances diagnostic certainty of ovarian cancer following indeterminate ultrasound [Classics Series]

RelatedReports

Many new pediatric asthma cases attributable to obesity

Chronic Disease

GLP-1 receptor agonists show little effect on obesity-related cancer risk

December 8, 2025

Population-based risk factors and geographical trends identified for vitiligo

Oncology

Increasing cancer incidence rates in younger and older adults worldwide

October 20, 2025

Selpercatinib may provide an effective response against RET-mutated thyroid cancer

Chronic Disease

Postoperative radioiodine ablation does not reduce cancer recurrence following thyroidectomy

July 31, 2025

#VisualAbstract: Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis

StudyGraphics

#VisualAbstract: Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer

November 24, 2023

Non-invasive ventilation linked with lower mortality in COPD exacerbations

Racial differences exist in emphysema prevalence in adults with normal spirometry findings

MRI effective for the assessment of acute appendicitis in pregnancy [Classics Series]

Parental debt influences child socioemotional well-being

Type of compensation model influences gender pay gap in primary care

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports